Table 1 Number and percentage of cases according to components of therapy in patients with KD at the NUNH Hospital in patients in the 19th Nationwide survey (2005–6) and the first cohort (low-dose IVIG)
19thNationwide survey (2005–2006) | First cohort (2004–2008) | p-value | |||
|---|---|---|---|---|---|
Total | 20,475 | 100.0 | 126 | 100.0 | |
Dosage of IVIG | Cases | % | Cases | % | |
2 g/kg | 11,612 | 56.7 | 3 | 2.1 | 0.001 |
1 g/kg/day × 2 d | 4,800 | 23.4 | 3 | 2.1 | 0.001 |
400 mg/kg/day × 5 d | 231 | 1.1 | 95 | 75.4 | 0.001 |
Various dosages of IVIG | 879 | 4.3 | 0 | 0 | 0.01 |
Aspirin alone (no IVIG) | 2,866 | 14.0 | 25 | 19.8 | 0.07 |
Dalteparin | 0 | 0 | 126 | 100.0 | |
Age (months) | -* | 22 (0–167) | |||
Male sex | 11,892 (58.1%) | 68 (54.0%) | 0.37 | ||